FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine and can be used for modification of eating behaviour in a subject. For this purpose peripheral introduction of PYY in an amount, efficient for achieving physiological levels of PYY3-36 in blood, plasma and serum, determined after food intake, is performed; or performed is peripheral introduction of PYY agonist in an amount, efficient for imitation of physiological levels of PYY3-36 in blood, plasma or serum, determined after food intake with modification of eating behaviour, by reducing intake of calories, food consumption or appetite reduction or increase of energy consumption in the subject. Also claimed is application of PYY or its agonist as an active ingredient in production of medication.
EFFECT: group of inventions provides weight reduction in the subject due to reduction of intake of calories, appetite reduction or increase of energy consumption in the subject.
50 cl, 9 dwg, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PEPTIDES HAVING AGONISTIC ACTIVITY ON NEUROPEPTIDE-2 RECEPTOR (Y2R) | 2006 |
|
RU2383553C2 |
| SELECTIVE COMPOUNDS OF YY PEPTIDE AND USE THEREOF | 2016 |
|
RU2726777C2 |
| METHODS FOR INDUCING AND PROLONGING SATURATION, REDUCING VOLUME AND ABSORPTION OF FOOD, CONTROLLING WEIGHT AND STIMULATING WEIGHT LOSS | 2017 |
|
RU2766585C2 |
| COMPOSITION FOR TREATING IGF-1R EXPRESSING CANCER | 2016 |
|
RU2728568C2 |
| LONG-ACTING AGONISTS OF RECEPTORS Y2 AND(OR) Y4 | 2009 |
|
RU2504550C2 |
| PHARMACEUTICAL AND NUTRITIONAL COMPOSITIONS FOR INDUCING SATIETY AND PROLONGING THE SATIETY SENSATION IN THE SUBJECTS IN NEED THEREOF | 2015 |
|
RU2717018C2 |
| METHOD FOR TREATMENT OF DISORDERS ASSOCIATED WITH MELANOCORTIN 4 RECEPTOR PATH | 2016 |
|
RU2785889C1 |
| MOLECULES OF ANTIBODIES TO PD-1 AND THEIR USE | 2016 |
|
RU2788092C2 |
| ANALOGUES OF INSULIN-LIKE GROWTH FACTOR-1 (IGF-1), CONTAINING AMINO ACID SUBSTITUTION IN POSITION 59 | 2010 |
|
RU2511577C2 |
| ANTIBODY AND DRUG CONJUGATES (ADC) AND ANTIBODY AND PRODRUG CONJUGATES (APDC) CONTAINING ENZYMATICALLY CLEAVABLE GROUPS | 2016 |
|
RU2751512C2 |
